Pharma & Biotech Policy Outlook: Drug Pricing in Focus

Duane Wright

Senior Research Analyst

Bloomberg Intelligence

Duane Wright is a Senior Analyst for the health team at Bloomberg Intelligence. Prior to joining Bloomberg he was a Vice President in the Government Affairs department for the Advanced Medical Technology Association (AdvaMed) where he was team lead on diagnostics, coverage and reimbursement issues, and led industry efforts to repeal the medical device tax in 2019. Prior to AdvaMed he was a Vice President at Finsbury Glover Hering, a multi-client consultant firm, and America’s Health Insurance Plans. Prior to his private sector work he was lead health staff for Senator Tom Carper (D-DE), and a Legislative Assistant to former Congressman Jim Davis (D-FL). Wright holds a law degree from The George Washington University, and a bachelor’s degree from the University of North Carolina at Chapel Hill.

Aude Gerspacher

Global Head of Healthcare

Bloomberg Intelligence

Aude Gerspacher is the Global Head of Healthcare Research at Bloomberg Intelligence. Prior to her current role, Ms. Gerspacher was the U.S. Director of Research for the regional equities team. She specializes in litigation and patent disputes in pharmaceuticals and biotechnology. Previously, Ms. Gerspacher worked as a Senior Corporate Counsel at Pfizer. Before transitioning in-house, Ms. Gerspacher worked as a patent attorney at Cozen O'Connor, a large full service law firm and Cooper & Dunham, a patent boutique firm in New York City. Ms. Gerspacher is a licensed patent attorney barred in the state of New York. She holds a bachelor of science in microbiology, a master of science in molecular biology and genetics, and a JD from Case Western University.